Is there a way to slow the process of bacterial antibiotic resistance?

April 10, 2014, Tufts University
Is there a way to slow the process of bacterial antibiotic resistance?
As patients, we should use antibiotics only when needed—for bona fide bacterial infections, says Stuart Levy. Credit: DepositPhotos

Continually under attack by noxious substances in their environments, bacteria have developed many clever mechanisms to survive. When confronted with an antibiotic, they can destroy it with enzymes, rendering it harmless. Some can transport the antibiotic out of a cell via what are called efflux pumps, thereby protecting the inner cell. Alternatively, they can substitute a drug-resistant target for one that is susceptible to the antibiotic.

They do all this by assimilating one or more genes into their genome, mitigating the effect of a drug that attacks them. For example, a bacterium initially may be susceptible to the , but through a variety of gene exchanges, it can incorporate a tetracycline-resistance gene, which then programs the bacteria to resist tetracycline.

It's these newly resistant bacteria that can spread their resistance to other bacteria in the environment. They typically do this by a "mating" process that is unique to bacteria. Bacteria are notoriously promiscuous with their DNA, and although each may be evolutionarily distinct, they are completely capable of adding their resistance traits to many diverse types of bacteria.

In many respects, this activity is so dramatic, and the genes so versatile and dispersed, that it truly rivals science fiction. The recognition that bacteria could become multidrug-resistant came as a surprise in the late 1950s and early 1960s. Over the span of a few decades, resistance to single has been replaced with . The arena of infectious disease is now beset with multidrug-resistant bacteria, undermining our capacity to cure formerly treatable illnesses and leading the Centers for Disease Control (CDC) to issue warnings of "nightmare ."

How can we combat resistance? The classic approach has been to continually develop new antibiotics that can circumvent these resistance mechanisms. But the pipeline for is now nearly dry. Thus, we must aggressively pursue alternative approaches in both our homes and our health-care institutions. Prevention of infection will, of course, avoid the problem altogether, and proper hygiene—that is, regular hand washing—is a proven but still largely underutilized intervention.

As patients, we should use antibiotics only when needed—for bona fide bacterial infections and not for viral infections such as a cold, flu or bronchitis. When antibiotics are prescribed, we should take the complete prescription as directed by the physician. We must refrain from stockpiling partial doses for future use. By using antibiotics appropriately, we can avoid the selection and subsequent buildup of resistance traits, all of which are potentially transmissible beyond the individual to society at large.

In our health-care institutions, we must focus concerted efforts on becoming better stewards of our antibiotic resources through coordinated monitoring of antibiotic usage to reduce overuse and misuse. Casual attitudes toward antibiotics must be modified, and preserving the effectiveness of antibiotics must be encouraged, or we will lose the efficacy of the precious resources that have revolutionized our treatment of infectious disease.

Explore further: CDC addresses burden, threat of antibiotic resistance

Related Stories

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Number of patients admitted with antibiotic-resistant infections rising

March 25, 2014
The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published ...

Antibiotics – friend and foe?

November 18, 2013
European Antibiotic Awareness Day is marked on the 18th November every year. This year in Norway, a seminar for health care providers about antibiotic use and resistance will be held, as well as several local events around ...

Evolution winning in bacteria vs antibiotics arms race

November 19, 2013
Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.